InsidersTradesSigma
Track the CMG제약 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, CMG제약 has published 7 public disclosures. Market capitalisation: €104.1bn. The latest transaction was reported on 11 March 2026 (Other). Among the most active insiders: CMG제약. Every trade is free.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
1 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,190 of 29,062 companies
25.3
score / 100
Value9
Quality41
FCF yld-48%
Earn yld-11%
EV/EBITDA·
ROE2.3%
Gross mgn58%
Net mgn-9.6%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 11 March 2026
关于 CMG제약
CMG제약是一家在XKRX市场上市的医疗保健和制药公司。它专注于药品的开发和商业化。